While CMG2 mRNA exhibited no significant association with the patients’ outcome in the different histological subclasses, patients with high-stage tumors (3 + 4) and lower CMG2 mRNA expression exhibited a significant worsened survival than high-stage soft tissue sarcoma patients with elevated CMG2 mRNA expression (11 versus 23 months median survival time in Kaplan-Maier survival analyses). Here, ANTXR2 is linked to soft tissue sarcoma.